Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) — Sponsor Intelligence | 94 EU Trials

Filter these 94 trials by condition, phase, country and more.

Open in Search →

94 Registered trials

45 Recruiting

21 Completed trials

14 Countries active

123 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 15 Phase II/III: 3 Phase II: 17 Phase I/II: 7 Phase III/IV: 8 Phase IV: 27 Phase I: 3 Phase I (Other): 8 Phase I (FiH): 4 Other: 2

Oversight events:

3 serious breaches 1 temporary halt across 4 trials

View oversight register →

100%

21 of 21 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Glioblastoma multiforme 2 Rheumatoid arthritis 1 Cancer pain 1 Laser speckle contrast imaging 1 Prostate cancer metastatic 1 Complex regional pain syndrome 1 Oxytocin 1 Trigeminal nerve disorder 1 Cardiac sarcoidosis 1 Migraine 1

Top IMPs

IRINOTECAN HYDROCHLORIDE TRIHYDRATE 5 FLUOROURACIL 4 FOLINIC ACID 4 OXALIPLATIN 4 NIVOLUMAB 3 PEMBROLIZUMAB 3 (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 2 [AL[18F]F]FAPI-74 2 ALGLUCOSIDASE ALFA 2 AMOXICILLIN 2 AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES 2 AVALGLUCOSIDASE ALFA 2

All trials — page 2

94 total

Repurposed Drugs in Research and Cancer Clinical Trials. The ReDiReCCT trial Vemurafenib Pending

2025-523340-12-00 Phase I (Other) 1 country
New PET/CT for (possible) cardiac sarcoidosis Pending

2025-523646-27-00 Phase II 1 country GALLIUM (68GA), PENTIXAFOR
The Surf trial Pending

2025-523898-42-00 Phase II/III 1 country INDOCYANINE GREEN
PLUTO Pending

2026-525211-14-00 Phase II 1 country
Adjuvant chemotherapy for prevention of recurrence in patients with detectable ctDNA after surgery in high-riskrectal cancer. Recruiting

2024-517700-12-00 Phase III 1 country CALCIUM FOLINATE
T3-4-Hypo trial Recruiting

2024-513883-24-00 Phase III 1 country
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Recruiting

2024-510617-15-00 Phase III 2 countries FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT Recruiting

2024-511568-96-00 Phase IV 2 countries
Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment Recruiting

2023-507481-43-00 Phase III/IV 1 country DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia Recruiting

2023-504694-20-00 Phase I/II 13 countries INOTUZUMAB OZOGAMICIN
AchilleS tendinoPathy treated with cortIcosteRoid injEctions. Recruiting

2025-524057-13-00 Phase III 1 country
The STELLAR trial: Fluorescence-guided surgery in laryngeal- and hypopharyngeal cancer: a feasibility trial Recruiting

2024-519750-36-00 Phase I (FiH) 1 country CRGD-ZW800-1
Peri-operative intraperitoneal irinotecan and systemic FLOT in the curative treatment of gastric cancer and gastroesophageal junction cancer… Recruiting

2025-522864-34-00 Phase I (Other) 1 country IRINOTECAN HYDROCHLORIDE TRIHYDRATE
INTERACT-FAPI Recruiting

2024-520037-76-00 Phase I (Other) 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Inhaled corticosteroids in young children with episodic wheezing: a multicenter cluster RCT Recruiting

2025-522694-11-00 Phase IV 1 country
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Recruiting

2024-514693-47-01 Phase III/IV 2 countries OSIMERTINIB
INTERACT stomach-II Recruiting

2025-521468-36-00 Phase II 1 country IRINOTECAN HYDROCHLORIDE TRIHYDRATE
Total Neoadjuvant Therapy for lymph node-positive adenocarcinoma of the OESophagus and oesophagogastric junction: TNT-OES-2 trial Recruiting

2025-521158-40-00 Phase II 1 country CARBOPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PACLITAXEL
[18F]Tetrafluoroborate PET/CT for the Detection of Differentiated Thyroid Cancer: A Phase II Imaging Study Recruiting

2024-516025-30-00 Phase II 1 country TETRAFLUOROBORATE ION F-18
Phase 0 trial of CBD in recurrent glioblastoma patients Recruiting

2024-513357-74-01 Phase I (Other) 1 country
Tacrolimus monotherapy in elderly kidney transplant recipients Recruiting

2024-517709-10-00 Phase IV 1 country
Treatment frequency Reduction In POmpe disease (TRIPO-Study) Recruiting

2024-514255-15-01 Phase IV 1 country ALGLUCOSIDASE ALFA; AVALGLUCOSIDASE ALFA; CIPAGLUCOSIDASE ALFA; MIGLUSTAT
Exploratory Study of CAPEcitabine pharmacokinetics and hand-foot syndrome in CES1 variant carriers: the ESCAPE study Recruiting

2024-516788-96-00 Phase IV 1 country
BuLLSEYE Recruiting

2024-512950-13-00 Phase III/IV 1 country AMOXICILLIN; AMOXICILLIN, AMOXICILLIN, CLAVULANIC ACID, CLAVULANIC ACID; CEFOTAX…

Showing 25–48 of 94 trials

← All sponsors A–Z